Champions Oncology (CSBR) Net Margin (2010 - 2026)
Champions Oncology (CSBR) posted quarterly Net Margin of 4.82% for Q2 2026, up 1003.0% year-over-year from 0.44% in Q2 2025, and down 186.14% quarter-over-quarter from 1.68% in Q1 2026.
Champions Oncology (CSBR) Net Margin (2010 - 2026) Analysis & Trends
Champions Oncology's Net Margin history runs 17 years deep, the most recent figure standing at 4.82% for Q2 2026.
- In Q2 2026, Net Margin rose 1003.0% year-over-year to 4.82%; the TTM figure through Apr 2026 stood at 1.98% (down 1023.0% YoY), while the FY2026 annual figure was 1.98%, down 1023.0% from the prior year.
- Net Margin for Q2 2026 stood at 4.82%, down from 1.68% in the prior quarter.
- The five-year high for Net Margin was 26.38% in Q1 2025, with the low at 21.05% in Q1 2024.
- The 5-year median for Net Margin is 2.5% (2022), against an average of 4.44%.
- The sharpest annual moves came in 2025 and 2026: Net Margin jumped 4743 bps in 2025, then plunged 2807 bps in 2026.
- Champions Oncology's Net Margin stood at 0.11% in 2022, then tumbled by 15872 bps to 17.9% in 2023, then soared by 130 bps to 5.4% in 2024, then sank by 71 bps to 1.58% in 2025, then sank by 406 bps to 4.82% in 2026.
- Business Quant data shows CSBR's Net Margin at 4.82% in Q2 2026, 1.68% in Q1 2026, and 1.58% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -539.31% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 13.90% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 12.74% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -3.12% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -16.51% |
| 10 | Champions Oncology | 71.17 Mn | 71.17 Mn | 7.03 Mn | -4.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -4.82% |
| Jan 31, 2026 | -1.68% |
| Oct 31, 2025 | 1.58% |
| Jul 31, 2025 | -3.33% |
| Apr 30, 2025 | -14.85% |
| Jan 31, 2025 | 26.38% |
| Oct 31, 2024 | 5.40% |
| Jul 31, 2024 | 9.34% |
| Apr 30, 2024 | -0.78% |
| Jan 31, 2024 | -21.05% |
| Oct 31, 2023 | -17.90% |
| Jul 31, 2023 | -20.43% |
| Apr 30, 2023 | -19.59% |
| Jan 31, 2023 | -19.09% |
| Oct 31, 2022 | -0.11% |
| Jul 31, 2022 | -2.32% |
| Apr 30, 2022 | -2.67% |
| Jan 31, 2022 | 5.97% |
| Oct 31, 2021 | 2.35% |
| Jul 31, 2021 | -1.53% |